Atherectomy Devices Market Application, Technology and Development Trend up to 2022 by Million Insights

on

Global Atherectomy Devices Market is expected to witness rapid growth over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in Atherectomy Devices Market growth in the foreseeable future. Change in lifestyle trends and eating habits increase Consumption of cholesterol and fatty foods among individuals and lack of exercise which has been a major reason for coronary artery disease and high risk of heart attacks. Depending on the severity of the health issue atherectomy devices are used in the surgery by the doctors.
Diabetes, high blood pressure, obesity and smoking causes the blood arteries to marrow and limit the blood supply to the heart. It is estimated that 382 billion people throughout the world have diabetes. Environmental factors such as foods, viruses, toxins and unbalanced work life play a role in development of diabetes. Growing number of patients with these vascular diseases are expected to proliferate the demand for atherectomy devices. Adopting advanced technology by using laser, ultraviolet radiation and recombinant issue technology and 3D image generation provides a better scope for the Atherectomy devices market. Added benefits such as minimal incisions, higher surgical restoration rate, low postoperative complications increase more patients opting for atherectomy devices.
New technological advancements and the recent FDA approval of Two drug coated balloons are increasing atherectomy procedural volume and driving growth in the demand for atherectomy devices Recalls of medical devices has beena major issue in pharmaceutical industry. Every device should maintain the standard quality and safety measures set by the Food and Drug Administration (FDA). All the manufacturing firms should ensure that the products are safe and do not endanger the end consumer. Athrectomy devices face a tough competition from Catheter (Tornus) which has been developed for chronic total occlusion recanalization. However, Catheter has a lower success rate of only 77% as compared to the traditional atherectomy devices with 95%. Tornus catheter is also associated with longer procedural duration time with 144 minutes versus the atherectomy devices 115 minutes.
Lack of product differentiation forms a major challenge in the atherectomy Devices market. Most companies trying to enter the market find it hard to overcome the product differentiation because they require high investment and lack resources to create products that can compete with the existing ones. High cost and limited awareness in certain regions of the world act as a restraint for the market growth.  Atherectomy technique is a popular substitute for stents and angioplasty treatments. In stents and angioplasty, the deposited plaque is pushed inside the blood vessel, however in atherectomy the plaque is removed by using surgical methods. The technique has advantages over the other methods by providing increased wound healing rate  The Atherectomy Devices Market has been classified on the basis of its device functions such as rotational, orbital, excimer laser, excisional, directional and Jetstream atherectomy. The largest share of the market is occupied by orbital and directional atherectomy due to minimal invasive treatment, blood flow restoration, reduction in procedure time and application in more complex cases. Market players are coming with better techniques and products to meet the requirement of the consumers.
Reduction of abdominal obesity through lifestyle measures can improve all components of the metabolic syndrome and likely delay the development of both diabetes and atherosclerosis. Beyond lifestyle intervention, optimal management of risk factors to evidence-based targets is essential. High awareness of health problems caused due to change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and likely reduce the development of both diabetes and atherosclerosis and hence reducing the demand for the atherectomy devices. The major companies of the Atherectomy Devices Market include Bayer AG, Cardiovascular systems, St. Jude medica, Boston scientific corporation, Abbott laboratories, C.R Bard Inc., Volcano Corporation. The competition in this Atherectomy Devices Market usually depends on the technology used in manufacturing of the devices and also the pricing strategies. Medtronic’s is leading competitor in peripheral atherectomy devices. Medtronic acquired Covedian in 2015 and is expected to remain in the leading position however it will face increasing competition from cardiovascular systems Inc.

Comments

Post a Comment